Clinical Trials › NCT05122559
Active, Not RecruitingPhase 2
Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis
Sponsored by Emmanuelle Waubant, MD PhD
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 98
Target enrollment
1
U.S. states
Feb 2022
Start date
Feb 2027
Expected completion
Interventions / Treatments
N-acetyl cysteinePlacebo
Conditions studied
Multiple SclerosisMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
Where this trial is running (1 site)
California1 site
San Francisco
Participating MS centers on MS Buddy (1)
UCSF Multiple Sclerosis Center
San Francisco, CA
San Francisco, CA
MS centers in California
Compare treatment centers near a trial site by center type, providers and trials.
View California centersMore Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.